Pneumocystis organisms were first believed to be a single protozoan species able to colonize the lungs of all mammals.Subsequently, genetic analyses revealed their affiliation to the fungal Taphrinomycotina subphylum of the Ascomycota, a clade which encompasses plant pathogens and free-living yeasts.It also appeared that, despite their similar morphological appearance, these fungi constitute a family of relatively divergent species, each with a strict specificity for a unique mammalian species [1].The species colonizing human lungs, Pneumocystis jirovecii, can turn into an opportunistic pathogen that causes Pneumocystis pneumonia (PCP) in immunocompromised individuals, a disease which may be fatal.Although the incidence of PCP diminished in the 1990s thanks to prophylaxis and antiretroviral therapy, PCP is nowadays the second-most-frequent, life-threatening, invasive fungal infection worldwide, with an estimated number of cases per year above 400,000 [2].Despite this clinical importance, studies of P. jirovecii progressed slowly, at least in part because of the lack of a continuous culture system.Nevertheless, recent genomic findings provided insights into the lifestyle of these fungi.
No takes yet. Share an insight, caveat, or question.
Philippe M. Hauser (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: